Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 110

1.

Sirolimus in liver transplant recipients: a large single-center experience.

Vivarelli M, Dazzi A, Cucchetti A, Gasbarrini A, Zanello M, Di Gioia P, Bianchi G, Tamè MR, Gaudio MD, Ravaioli M, Cescon M, Grazi GL, Pinna AD.

Transplant Proc. 2010 Sep;42(7):2579-84. doi: 10.1016/j.transproceed.2010.04.045.

PMID:
20832548
2.

Sirolimus therapy in liver transplant patients: an initial experience at a single center.

Nocera A, Andorno E, Tagliamacco A, Morelli N, Bottino G, Ravazzoni F, Casaccia M, Barocci S, Alice S, Santori G, Ghirelli R, Valente U.

Transplant Proc. 2008 Jul-Aug;40(6):1950-2. doi: 10.1016/j.transproceed.2008.05.005.

PMID:
18675098
3.

Improved renal function in sirolimus-treated renal transplant patients after early cyclosporine elimination.

Gonwa TA, Hricik DE, Brinker K, Grinyo JM, Schena FP; Sirolimus Renal Function Study Group..

Transplantation. 2002 Dec 15;74(11):1560-7.

PMID:
12490789
4.

Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: a meta-analysis.

Liang W, Wang D, Ling X, Kao AA, Kong Y, Shang Y, Guo Z, He X.

Liver Transpl. 2012 Jan;18(1):62-9. doi: 10.1002/lt.22441.

5.

Safety of an immunosuppressant protocol based on sirolimus in liver transplant recipients with malignancies or high risk of tumor recurrence.

Castroagudín JF, Molina E, Tomé S, Otero E, Rodríguez M, Varo E.

Transplant Proc. 2009 Apr;41(3):1003-4. doi: 10.1016/j.transproceed.2009.02.017.

PMID:
19376410
6.

Sirolimus-based immunosuppression therapy in liver transplantation for patients with hepatocellular carcinoma exceeding the Milan criteria.

Zhou J, Wang Z, Wu ZQ, Qiu SJ, Yu Y, Huang XW, Tang ZY, Fan J.

Transplant Proc. 2008 Dec;40(10):3548-53. doi: 10.1016/j.transproceed.2008.03.165.

PMID:
19100435
7.

Sirolimus-based immunosuppressive therapy in liver transplant recipient with tacrolimus-related chronic renal insufficiency.

Yang YJ, Chen DZ, Li LX, Kou JT, Lang R, Jin ZK, Han DD, He Q.

Transplant Proc. 2008 Jun;40(5):1541-4. doi: 10.1016/j.transproceed.2008.01.081.

PMID:
18589147
8.

Early sirolimus therapy in renal transplant recipients at high risk: is it justified?

Halim MA, Al-Otaibi T, Johny KV, Hamid MH, Al-Waheeb S, Hasaneen H, Awadain WH, Nawas KM, El-Sayed A, Said T, Nair MP, Nampoory MR.

Transplant Proc. 2009 Sep;41(7):2784-8. doi: 10.1016/j.transproceed.2009.07.015.

PMID:
19765435
9.

Conversion to sirolimus-based maintenance immunosuppression using daclizumab bridge therapy in renal transplant recipients.

Sundberg AK, Rohr MS, Hartmann EL, Adams PL, Stratta RJ.

Clin Transplant. 2004;18 Suppl 12:61-6.

PMID:
15217410
10.

Indications and management of everolimus after liver transplantation.

Bilbao I, Sapisochin G, Dopazo C, Lazaro JL, Pou L, Castells L, Caralt M, Blanco L, Gantxegi A, Margarit C, Charco R.

Transplant Proc. 2009 Jul-Aug;41(6):2172-6. doi: 10.1016/j.transproceed.2009.06.087.

PMID:
19715864
11.

Sirolimus conversion in liver transplant recipients with renal dysfunction: a prospective, randomized, single-center trial.

Shenoy S, Hardinger KL, Crippin J, Desai N, Korenblat K, Lisker-Melman M, Lowell JA, Chapman W.

Transplantation. 2007 May 27;83(10):1389-92.

PMID:
17519792
12.

Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience.

Zhou J, Fan J, Wang Z, Wu ZQ, Qiu SJ, Huang XW, Yu Y, Sun J, Xiao YS, He YF, Wang YQ, Tang ZY.

World J Gastroenterol. 2006 May 21;12(19):3114-8.

13.

Absence of proteinuria predicts improvement in renal function after conversion to sirolimus-based immunosuppressive regimens in lung transplant survivors with chronic kidney disease.

Stephany BR, Boumitri M, Budev M, Alao B, Poggio ED.

J Heart Lung Transplant. 2009 Jun;28(6):564-71. doi: 10.1016/j.healun.2009.03.010.

PMID:
19481016
14.

Replacement of calcineurin-inhibitors with sirolimus as primary immunosuppression in stable cardiac transplant recipients.

Raichlin E, Khalpey Z, Kremers W, Frantz RP, Rodeheffer RJ, Clavell AL, Edwards BS, Kushwaha SS.

Transplantation. 2007 Aug 27;84(4):467-74.

PMID:
17713429
15.

Conversion from calcineurin inhibitors to sirolimus maintenance therapy in renal allograft recipients: 24-month efficacy and safety results from the CONVERT trial.

Schena FP, Pascoe MD, Alberu J, del Carmen Rial M, Oberbauer R, Brennan DC, Campistol JM, Racusen L, Polinsky MS, Goldberg-Alberts R, Li H, Scarola J, Neylan JF; Sirolimus CONVERT Trial Study Group..

Transplantation. 2009 Jan 27;87(2):233-42. doi: 10.1097/TP.0b013e3181927a41.

PMID:
19155978
16.

Effect of different immunosuppressive schedules on recurrence-free survival after liver transplantation for hepatocellular carcinoma.

Vivarelli M, Dazzi A, Zanello M, Cucchetti A, Cescon M, Ravaioli M, Del Gaudio M, Lauro A, Grazi GL, Pinna AD.

Transplantation. 2010 Jan 27;89(2):227-31. doi: 10.1097/TP.0b013e3181c3c540.

PMID:
20098287
17.

Impact of the conversion of the immunosuppressive regimen from prograf to advagraf or to sirolimus in long-term stable liver transplant recipients: indications, safety, and outcome.

Perrakis A, Schwarz K, Yedibela S, Croner RS, Hohenberger W, Müller V.

Transplant Proc. 2011 Dec;43(10):3702-7. doi: 10.1016/j.transproceed.2011.09.015.

PMID:
22172830
18.

Conversion to sirolimus-based immunosuppression in maintenance liver transplantation patients.

Morard I, Dumortier J, Spahr L, Hadengue A, Majno P, Morel P, Mentha G, Giostra E.

Liver Transpl. 2007 May;13(5):658-64.

19.

Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens.

McTaggart RA, Tomlanovich S, Bostrom A, Roberts JP, Feng S.

Transplantation. 2004 Aug 15;78(3):475-80.

PMID:
15316379
20.

Sirolimus-based calcineurin inhibitor withdrawal immunosuppressive regimen in kidney transplantation: a single center experience.

Alarrayed SM, El-Agroudy AE, Alarrayed AS, Al Ghareeb SM, Garadah TS, El-Sharqawi SY, Al-Aradi AH, Dandi BG, Abdulla S.

Clin Exp Nephrol. 2010 Jun;14(3):248-55. doi: 10.1007/s10157-010-0269-0. Epub 2010 Mar 16.

PMID:
20232105

Supplemental Content

Support Center